Carmen Mecca

4PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 08, 2022
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.

Jacob D Soumerai, Allison Rosenthal, Shannon Harkins

|May 16, 2019
Niemann-Pick Type A Disease: Behavior of Neutral Sphingomyelinase and Vitamin D Receptor.

Carmela Conte, Cataldo Arcuri, Samuela Cataldi

|Jan 22, 2019
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence.

Carmen Mecca, Ileana Giambanco, Rosario Donato

Pageof 1